In abdominal obesity, visceral fat deposits become enlarged and dysfunctional and produce inflammatory biomarkers like C-reactive protein (CRP), cytokines, tumor necrosis factor-alpha (TNF-a), prostaglandins, and leptin [4,5]. The gene discussed is CRP; the disease is Abdominal obesity.